empagliflozin可降低心力衰竭患者的心血管死亡率和住院风险

{"title":"empagliflozin可降低心力衰竭患者的心血管死亡率和住院风险","authors":"Natalia Ponce de Leon","doi":"10.51987/evidencia.v25i1.6976","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":34114,"journal":{"name":"Evidencia Actualizacion en la Practica Ambulatoria","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"La empagliflozina disminuye la mortalidad cardiovascular y el riesgo de hospitalización en pacientes con insuficiencia cardíaca\",\"authors\":\"Natalia Ponce de Leon\",\"doi\":\"10.51987/evidencia.v25i1.6976\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":34114,\"journal\":{\"name\":\"Evidencia Actualizacion en la Practica Ambulatoria\",\"volume\":\"42 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidencia Actualizacion en la Practica Ambulatoria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51987/evidencia.v25i1.6976\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidencia Actualizacion en la Practica Ambulatoria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51987/evidencia.v25i1.6976","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}